KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Revenue (2016 - 2025)

Historic Revenue for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $84.1 million.

  • Fulgent Genetics' Revenue rose 1718.08% to $84.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $315.5 million, marking a year-over-year increase of 1360.45%. This contributed to the annual value of $283.5 million for FY2024, which is 198.57% down from last year.
  • Per Fulgent Genetics' latest filing, its Revenue stood at $84.1 million for Q3 2025, which was up 1718.08% from $81.8 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Revenue registered a high of $359.4 million during Q1 2021, and its lowest value of $64.5 million during Q1 2024.
  • Over the past 5 years, Fulgent Genetics' median Revenue value was $81.8 million (recorded in 2025), while the average stood at $127.6 million.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 453599.9% in 2021, then plummeted by 7933.98% in 2023.
  • Over the past 5 years, Fulgent Genetics' Revenue (Quarter) stood at $251.7 million in 2021, then plummeted by 73.1% to $67.7 million in 2022, then grew by 4.14% to $70.5 million in 2023, then grew by 8.1% to $76.2 million in 2024, then grew by 10.31% to $84.1 million in 2025.
  • Its last three reported values are $84.1 million in Q3 2025, $81.8 million for Q2 2025, and $73.5 million during Q1 2025.